Dynamic Medical Technologies Inc. (TPEX: 4138)
90.20
-4.80 (-5.05%)
Sep 10, 2024, 1:30 PM CST
Dynamic Medical Technologies Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 1,589 | 1,594 | 1,292 | 1,028 | 1,009 | 1,178 | Upgrade
|
Revenue | 1,589 | 1,594 | 1,292 | 1,028 | 1,009 | 1,178 | Upgrade
|
Revenue Growth (YoY) | 5.25% | 23.37% | 25.63% | 1.87% | -14.33% | 1.15% | Upgrade
|
Cost of Revenue | 1,002 | 990.45 | 839.16 | 673.6 | 691.27 | 844.03 | Upgrade
|
Gross Profit | 587.38 | 603.05 | 452.53 | 354.58 | 318.04 | 334.17 | Upgrade
|
Selling, General & Admin | 344.96 | 337.43 | 297.04 | 192.89 | 173.59 | 173.13 | Upgrade
|
Operating Expenses | 346.51 | 334.5 | 294.2 | 194.16 | 177.19 | 176.35 | Upgrade
|
Operating Income | 240.88 | 268.56 | 158.33 | 160.42 | 140.85 | 157.82 | Upgrade
|
Interest Expense | -4.04 | -2.45 | -1.33 | -0.87 | -1.01 | -1.22 | Upgrade
|
Interest & Investment Income | 35.98 | 27.75 | 14.11 | 6.98 | 11.22 | 10.22 | Upgrade
|
Earnings From Equity Investments | -1.26 | 1.05 | -2.6 | 0.86 | -2.06 | -10.75 | Upgrade
|
Currency Exchange Gain (Loss) | 4.19 | 1.3 | 7 | -0.59 | -2.69 | -0.16 | Upgrade
|
Other Non Operating Income (Expenses) | 1.01 | 1.09 | 2.64 | 7.04 | 2.44 | 4.35 | Upgrade
|
EBT Excluding Unusual Items | 276.75 | 297.31 | 178.16 | 173.82 | 148.75 | 160.28 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.02 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.73 | - | - | - | -0.06 | -0.29 | Upgrade
|
Pretax Income | 277.48 | 297.31 | 178.16 | 173.82 | 148.69 | 159.98 | Upgrade
|
Income Tax Expense | 56.47 | 59.54 | 38.3 | 32.13 | 32.05 | 33.9 | Upgrade
|
Earnings From Continuing Operations | 221.01 | 237.76 | 139.86 | 141.69 | 116.64 | 126.07 | Upgrade
|
Minority Interest in Earnings | -23.91 | -27.44 | -2.75 | -18.48 | -0.65 | -13.55 | Upgrade
|
Net Income | 197.1 | 210.32 | 137.11 | 123.21 | 116 | 112.52 | Upgrade
|
Net Income to Common | 197.1 | 210.32 | 137.11 | 123.21 | 116 | 112.52 | Upgrade
|
Net Income Growth | 11.91% | 53.39% | 11.29% | 6.22% | 3.09% | 7.19% | Upgrade
|
Shares Outstanding (Basic) | 36 | 36 | 36 | 36 | 36 | 36 | Upgrade
|
Shares Outstanding (Diluted) | 36 | 36 | 36 | 36 | 36 | 36 | Upgrade
|
Shares Change (YoY) | 0.01% | -0.05% | -0.07% | -0.02% | 0.04% | 0.04% | Upgrade
|
EPS (Basic) | 5.43 | 5.79 | 3.78 | 3.39 | 3.20 | 3.10 | Upgrade
|
EPS (Diluted) | 5.41 | 5.77 | 3.76 | 3.38 | 3.18 | 3.08 | Upgrade
|
EPS Growth | 11.73% | 53.38% | 11.34% | 6.24% | 3.22% | 7.18% | Upgrade
|
Free Cash Flow | 197.18 | 290.43 | 162.88 | 235.37 | 240.37 | 235.37 | Upgrade
|
Free Cash Flow Per Share | 5.41 | 7.97 | 4.47 | 6.45 | 6.59 | 6.45 | Upgrade
|
Dividend Per Share | 6.136 | 6.136 | 2.603 | 3.058 | 2.893 | 2.769 | Upgrade
|
Dividend Growth | 135.72% | 135.72% | -14.87% | 5.71% | 4.48% | 6.35% | Upgrade
|
Gross Margin | 36.96% | 37.84% | 35.03% | 34.49% | 31.51% | 28.36% | Upgrade
|
Operating Margin | 15.16% | 16.85% | 12.26% | 15.60% | 13.95% | 13.40% | Upgrade
|
Profit Margin | 12.40% | 13.20% | 10.61% | 11.98% | 11.49% | 9.55% | Upgrade
|
Free Cash Flow Margin | 12.41% | 18.23% | 12.61% | 22.89% | 23.82% | 19.98% | Upgrade
|
EBITDA | 331.08 | 353.33 | 221.05 | 214.53 | 184.25 | 192.43 | Upgrade
|
EBITDA Margin | 20.83% | 22.17% | 17.11% | 20.86% | 18.26% | 16.33% | Upgrade
|
D&A For EBITDA | 90.2 | 84.77 | 62.72 | 54.11 | 43.41 | 34.6 | Upgrade
|
EBIT | 240.88 | 268.56 | 158.33 | 160.42 | 140.85 | 157.82 | Upgrade
|
EBIT Margin | 15.16% | 16.85% | 12.26% | 15.60% | 13.95% | 13.40% | Upgrade
|
Effective Tax Rate | 20.35% | 20.03% | 21.50% | 18.49% | 21.55% | 21.19% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.